Anixa Biosciences Inc — Director's Dealing 2014

Jul 17, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2014-07-15

Reporting Person: KUMAR AMIT (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-07-15	Common Stock	P	100000	—	Acquired	1389691	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-07-15	Common Stock Purchase Warrants (Right to Buy)	$0.4	P	50000	Acquired	2019-07-15	Common Stock (50000)	Direct

Footnotes

F1: On July 15, 2014, Mr. Kumar purchased 100,000 shares of Common Stock, par value $0.01 per share, and 50,000 Warrants to purchase Common Stock, for an aggregate purchase price of $25,000 from CopyTele, Inc. in a registered direct offering.